Gal beta(1-3)[GlcNAc beta(1-6)]GalNAc-alpha-Thr2mg

1-Butyl-4-methylquinolin-2(1H)-one, 95.0%, 100mg

6-Benzyl-2,4-dichloro-5H-pyrrolo[3,4-d]pyrimidin-7(6H)-one, 95.0%, 1g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

(ETHYL 2-(ETHOXYCARBONYLAMINO)-4-METHYL-5-(4-NITROPHENYL)THIOPHENE-3-CARBOXYLATE), 95%, 25g

Ethynyl(diphenyl)phosphine Oxide, 98%, 250mg

TACROLIMUS, 98%, 50mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 5g

4-(Trifluoromethoxy)benzene-1,2-diamine, 95.0%, 5g

(E)-Trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-en-1-yl)silane, 98%, 250mg

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1S,2S)-2-(dimethylamino)-1,2-diphenylethyl]amino]-3-cyclobutene-1,2-dione, 97%, 1g

1,2-Propanediol, min. 99.5%, Ph.Eur., 2.5 l, plastic packaging.

ethyl 1-ethylpiperidine-4-carboxylate, 95.0%, 100g